nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—DRD4—Gilles de la Tourette syndrome	0.275	0.342	CbGaD
Bromocriptine—DRD3—Gilles de la Tourette syndrome	0.238	0.295	CbGaD
Bromocriptine—DRD2—Gilles de la Tourette syndrome	0.164	0.204	CbGaD
Bromocriptine—HTR2A—Gilles de la Tourette syndrome	0.127	0.158	CbGaD
Bromocriptine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00412	0.0822	CbGeAlD
Bromocriptine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00257	0.0513	CbGeAlD
Bromocriptine—Ergoloid mesylate—DRD2—Gilles de la Tourette syndrome	0.00193	0.392	CrCbGaD
Bromocriptine—DRD4—brain—Gilles de la Tourette syndrome	0.00127	0.0253	CbGeAlD
Bromocriptine—DRD3—nervous system—Gilles de la Tourette syndrome	0.00117	0.0232	CbGeAlD
Bromocriptine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00112	0.0224	CbGeAlD
Bromocriptine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00112	0.0224	CbGeAlD
Bromocriptine—DRD5—nervous system—Gilles de la Tourette syndrome	0.00109	0.0218	CbGeAlD
Bromocriptine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00108	0.0215	CbGeAlD
Bromocriptine—DRD5—central nervous system—Gilles de la Tourette syndrome	0.00105	0.021	CbGeAlD
Bromocriptine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00101	0.0202	CbGeAlD
Bromocriptine—Methylergometrine—HTR2A—Gilles de la Tourette syndrome	0.000903	0.183	CrCbGaD
Bromocriptine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000895	0.0179	CbGeAlD
Bromocriptine—DRD3—brain—Gilles de la Tourette syndrome	0.000891	0.0178	CbGeAlD
Bromocriptine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.000875	0.0175	CbGeAlD
Bromocriptine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000862	0.0172	CbGeAlD
Bromocriptine—HTR6—brain—Gilles de la Tourette syndrome	0.000857	0.0171	CbGeAlD
Bromocriptine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.000843	0.0168	CbGeAlD
Bromocriptine—DRD5—brain—Gilles de la Tourette syndrome	0.000835	0.0167	CbGeAlD
Bromocriptine—DRD1—nervous system—Gilles de la Tourette syndrome	0.000834	0.0166	CbGeAlD
Bromocriptine—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000822	0.0164	CbGeAlD
Bromocriptine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000803	0.016	CbGeAlD
Bromocriptine—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000796	0.0159	CbGeAlD
Bromocriptine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000788	0.0157	CbGeAlD
Bromocriptine—Methysergide—HTR2A—Gilles de la Tourette syndrome	0.000754	0.153	CrCbGaD
Bromocriptine—Ergotamine—DRD2—Gilles de la Tourette syndrome	0.000753	0.153	CrCbGaD
Bromocriptine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000684	0.0136	CbGeAlD
Bromocriptine—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000676	0.0135	CbGeAlD
Bromocriptine—ADRA1D—brain—Gilles de la Tourette syndrome	0.000669	0.0134	CbGeAlD
Bromocriptine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000664	0.0132	CbGeAlD
Bromocriptine—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000654	0.0131	CbGeAlD
Bromocriptine—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000651	0.013	CbGeAlD
Bromocriptine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000648	0.0129	CbGeAlD
Bromocriptine—DRD1—brain—Gilles de la Tourette syndrome	0.000638	0.0127	CbGeAlD
Bromocriptine—ADRB1—nervous system—Gilles de la Tourette syndrome	0.000636	0.0127	CbGeAlD
Bromocriptine—HTR7—midbrain—Gilles de la Tourette syndrome	0.000634	0.0127	CbGeAlD
Bromocriptine—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00063	0.0126	CbGeAlD
Bromocriptine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000624	0.0124	CbGeAlD
Bromocriptine—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.000612	0.0122	CbGeAlD
Bromocriptine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000609	0.0121	CbGeAlD
Bromocriptine—DRD2—midbrain—Gilles de la Tourette syndrome	0.0006	0.012	CbGeAlD
Bromocriptine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000586	0.0117	CbGeAlD
Bromocriptine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000583	0.0116	CbGeAlD
Bromocriptine—Ergotamine—HTR2A—Gilles de la Tourette syndrome	0.000582	0.118	CrCbGaD
Bromocriptine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000545	0.0109	CbGeAlD
Bromocriptine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000525	0.0105	CbGeAlD
Bromocriptine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000521	0.0104	CbGeAlD
Bromocriptine—HTR1B—brain—Gilles de la Tourette syndrome	0.000517	0.0103	CbGeAlD
Bromocriptine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000503	0.01	CbGeAlD
Bromocriptine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000502	0.01	CbGeAlD
Bromocriptine—HTR1D—brain—Gilles de la Tourette syndrome	0.0005	0.00998	CbGeAlD
Bromocriptine—HTR2C—brain—Gilles de la Tourette syndrome	0.000495	0.00988	CbGeAlD
Bromocriptine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000493	0.00983	CbGeAlD
Bromocriptine—ADRB1—brain—Gilles de la Tourette syndrome	0.000486	0.0097	CbGeAlD
Bromocriptine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000484	0.00966	CbGeAlD
Bromocriptine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000479	0.00956	CbGeAlD
Bromocriptine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000475	0.00947	CbGeAlD
Bromocriptine—HTR2B—brain—Gilles de la Tourette syndrome	0.000465	0.00928	CbGeAlD
Bromocriptine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000465	0.00928	CbGeAlD
Bromocriptine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000461	0.0092	CbGeAlD
Bromocriptine—HTR1A—brain—Gilles de la Tourette syndrome	0.000417	0.00832	CbGeAlD
Bromocriptine—HTR7—brain—Gilles de la Tourette syndrome	0.000398	0.00795	CbGeAlD
Bromocriptine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000395	0.00789	CbGeAlD
Bromocriptine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000384	0.00767	CbGeAlD
Bromocriptine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000382	0.00763	CbGeAlD
Bromocriptine—DRD2—brain—Gilles de la Tourette syndrome	0.000377	0.00752	CbGeAlD
Bromocriptine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000368	0.00734	CbGeAlD
Bromocriptine—ADRA2C—brain—Gilles de la Tourette syndrome	0.000366	0.00731	CbGeAlD
Bromocriptine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000325	0.00649	CbGeAlD
Bromocriptine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000313	0.00624	CbGeAlD
Bromocriptine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000301	0.006	CbGeAlD
Bromocriptine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000292	0.00583	CbGeAlD
Bromocriptine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00029	0.00578	CbGeAlD
Bromocriptine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000259	0.00517	CbGeAlD
Bromocriptine—HTR2A—brain—Gilles de la Tourette syndrome	0.000248	0.00496	CbGeAlD
Bromocriptine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000213	0.00425	CbGeAlD
Bromocriptine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000205	0.00409	CbGeAlD
Bromocriptine—ABCB1—brain—Gilles de la Tourette syndrome	0.000163	0.00325	CbGeAlD
Bromocriptine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.33e-05	0.000308	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.3e-05	0.000305	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.27e-05	0.000304	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.27e-05	0.000303	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.18e-05	0.000297	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.18e-05	0.000297	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.17e-05	0.000296	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.17e-05	0.000296	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.17e-05	0.000296	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.14e-05	0.000294	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.12e-05	0.000293	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.06e-05	0.000288	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.05e-05	0.000288	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.05e-05	0.000288	CbGpPWpGaD
Bromocriptine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.03e-05	0.000286	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.02e-05	0.000286	CbGpPWpGaD
Bromocriptine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.99e-05	0.000284	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.99e-05	0.000284	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.98e-05	0.000282	CbGpPWpGaD
Bromocriptine—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.98e-05	0.000282	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.94e-05	0.00028	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	3.89e-05	0.000276	CbGpPWpGaD
Bromocriptine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.85e-05	0.000273	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.81e-05	0.000271	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.79e-05	0.000269	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.79e-05	0.000269	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.78e-05	0.000268	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.77e-05	0.000268	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.76e-05	0.000267	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.75e-05	0.000266	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.7e-05	0.000263	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.69e-05	0.000262	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.68e-05	0.000262	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.68e-05	0.000261	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.67e-05	0.000261	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.65e-05	0.00026	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.63e-05	0.000258	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.62e-05	0.000257	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.61e-05	0.000257	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.59e-05	0.000255	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.59e-05	0.000255	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.58e-05	0.000254	CbGpPWpGaD
Bromocriptine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.58e-05	0.000254	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.55e-05	0.000252	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.49e-05	0.000248	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.46e-05	0.000246	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.46e-05	0.000246	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.45e-05	0.000245	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.45e-05	0.000245	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.44e-05	0.000245	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.44e-05	0.000245	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.43e-05	0.000244	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.43e-05	0.000243	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.43e-05	0.000243	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.4e-05	0.000242	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.36e-05	0.000239	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.35e-05	0.000238	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.33e-05	0.000237	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.3e-05	0.000234	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.28e-05	0.000233	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.26e-05	0.000232	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.25e-05	0.000231	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.23e-05	0.00023	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.22e-05	0.000229	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000228	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000228	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.2e-05	0.000227	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.17e-05	0.000225	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.14e-05	0.000223	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.13e-05	0.000222	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.13e-05	0.000222	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.13e-05	0.000222	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.11e-05	0.000221	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.11e-05	0.000221	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.09e-05	0.00022	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.08e-05	0.000218	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.04e-05	0.000216	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3e-05	0.000213	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.99e-05	0.000212	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.99e-05	0.000212	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.95e-05	0.00021	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.94e-05	0.000209	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.93e-05	0.000208	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.93e-05	0.000208	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.92e-05	0.000208	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.91e-05	0.000207	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.91e-05	0.000207	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.91e-05	0.000207	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.9e-05	0.000206	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.9e-05	0.000206	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.9e-05	0.000206	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.86e-05	0.000203	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	2.85e-05	0.000202	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.85e-05	0.000202	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.82e-05	0.000201	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.82e-05	0.0002	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.81e-05	0.000199	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.8e-05	0.000199	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.79e-05	0.000198	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.78e-05	0.000198	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.73e-05	0.000194	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.72e-05	0.000193	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.72e-05	0.000193	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.71e-05	0.000193	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000193	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.71e-05	0.000192	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.67e-05	0.00019	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.67e-05	0.00019	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.66e-05	0.000189	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.65e-05	0.000189	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.65e-05	0.000188	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.64e-05	0.000188	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.64e-05	0.000187	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.63e-05	0.000187	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.63e-05	0.000187	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.000186	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.62e-05	0.000186	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.61e-05	0.000186	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.6e-05	0.000184	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.59e-05	0.000184	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.57e-05	0.000183	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.54e-05	0.00018	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.54e-05	0.00018	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.53e-05	0.00018	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.53e-05	0.000179	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.46e-05	0.000175	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.46e-05	0.000174	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.43e-05	0.000173	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.43e-05	0.000172	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.42e-05	0.000172	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.42e-05	0.000172	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.41e-05	0.000172	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.000171	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.00017	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.39e-05	0.00017	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.38e-05	0.000169	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.37e-05	0.000169	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.36e-05	0.000168	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.36e-05	0.000168	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.35e-05	0.000167	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000166	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.31e-05	0.000164	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.3e-05	0.000163	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000162	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2.28e-05	0.000162	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.00016	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.00016	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.24e-05	0.000159	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.24e-05	0.000159	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.22e-05	0.000158	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.21e-05	0.000157	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.2e-05	0.000156	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.19e-05	0.000156	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.19e-05	0.000156	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.18e-05	0.000155	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.17e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.17e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.16e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.15e-05	0.000153	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.14e-05	0.000152	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.14e-05	0.000152	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	2.12e-05	0.00015	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.11e-05	0.00015	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.05e-05	0.000145	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.04e-05	0.000145	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.04e-05	0.000145	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.04e-05	0.000145	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.03e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.02e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.01e-05	0.000143	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2e-05	0.000142	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.99e-05	0.000141	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.97e-05	0.00014	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.96e-05	0.000139	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.95e-05	0.000138	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.94e-05	0.000138	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.93e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.9e-05	0.000135	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.89e-05	0.000135	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.87e-05	0.000133	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.86e-05	0.000132	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.86e-05	0.000132	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000131	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.85e-05	0.000131	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.85e-05	0.000131	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000131	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000131	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.78e-05	0.000126	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.000126	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.76e-05	0.000125	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.74e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.73e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.72e-05	0.000122	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.72e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000122	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.72e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.69e-05	0.00012	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.68e-05	0.00012	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.67e-05	0.000118	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.66e-05	0.000118	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000118	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.65e-05	0.000117	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.61e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.6e-05	0.000114	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.6e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.58e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.57e-05	0.000111	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.56e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.55e-05	0.00011	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.54e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.53e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.5e-05	0.000107	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.5e-05	0.000107	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.49e-05	0.000106	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.46e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.45e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.43e-05	0.000102	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.43e-05	0.000101	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.42e-05	0.000101	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.42e-05	0.000101	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.41e-05	0.0001	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.41e-05	0.0001	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.4e-05	9.96e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.4e-05	9.93e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.39e-05	9.88e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.38e-05	9.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.36e-05	9.67e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.36e-05	9.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.3e-05	9.26e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.3e-05	9.2e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.3e-05	9.2e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.27e-05	9.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.27e-05	8.99e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.22e-05	8.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.21e-05	8.56e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.21e-05	8.56e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.18e-05	8.37e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.1e-05	7.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.09e-05	7.73e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.05e-05	7.46e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.04e-05	7.42e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.02e-05	7.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1e-05	7.11e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.22e-06	6.55e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.89e-06	6.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.26e-06	5.86e-05	CbGpPWpGaD
